Jenburkt Pharmaceuticals Limited (BOM:524731)
India · Delayed Price · Currency is INR 943.00
-4.00 (-0.42%)
At close: Nov 6, 2026
Jenburkt Pharmaceuticals Market Cap
Jenburkt Pharmaceuticals has a market cap or net worth of 4.16 billion as of November 6, 2026. It is the 30,682nd most valuable company in the world and the 2,145th biggest in India. Its market cap has decreased by 25.29% in one year.
Market Cap
4.16B
Enterprise Value
3.37B
Revenue
1.71B
Global Rank
Country Rank
#2,145 India
PE Ratio
12.66
ChartMarket Cap Chart
Since November 21, 2001, Jenburkt Pharmaceuticals's market cap has increased from 33.01M to 4.16B, an increase of 12,507.51%. That is a compound annual growth rate of 21.37%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 4.16B | -13.47% |
| Dec 31, 2025 | 4.81B | -10.28% |
| Dec 31, 2024 | 5.36B | 78.59% |
| Dec 29, 2023 | 3.00B | 1.25% |
| Dec 30, 2022 | 2.96B | 21.19% |
| Dec 31, 2021 | 2.45B | 24.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kilitch Drugs (India) | 7.30B |
| ZIM Laboratories | 7.22B |
| Wanbury | 6.73B |
| Trident Lifeline | 4.99B |
| Albert David | 4.34B |
| Medicamen Biotech | 3.58B |
| Astonea Labs | 3.52B |
| Ambalal Sarabhai Enterprises | 2.73B |